Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts By Watertime - March 12, 2026 7 Post Content RELATED ARTICLESMORE FROM AUTHOR The Psychedelic Practitioner Issue 6: Preparedness (People) Two Years After Rejection, Resilient Quietly Refiles MDMA for PTSD Application Smooth Sailing: Definium’s LSD Voyage Hits Primary and Key Secondary Endpoints in GAD
